A Combined Human in Silico and CRISPR/Cas9-Mediated in Vivo Zebrafish Based Approach to Provide Phenotypic Data for Supporting Early Target Validation. (2022)

First Author: Winter MJ

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3389/fphar.2022.827686

PubMed Identifier: 35548346

Publication URI: http://europepmc.org/abstract/MED/35548346

Type: Journal Article/Review

Volume: 13

Parent Publication: Frontiers in pharmacology

ISSN: 1663-9812